医学
临时的
怀孕
接种疫苗
中期分析
回顾性队列研究
队列
食品药品监督管理局
疫苗安全性
儿科
队列研究
不利影响
急诊医学
梅德林
病毒
免疫
产科
脊髓灰质炎
临床试验
医疗保健
重症监护医学
作者
Ashley I. Michnick,Sarah C. MacDonald,Austin Cosgrove,Sruthi Adimadhyam,Fang Zhang,Andrew B. Petrone,Katherine E. Round,Sampada Gandhi,Nana Koram,Olympia E. Anastasiou,Heather Rubino,Maria Maddalena Lino,Djeneba Audrey Djibo,Kuntz Jl,S B Love,Vinit Nair,Kristin Palmsten,Anna E. Wentz,Judith C. Maro,Richard Platt
出处
期刊:JAMA
[American Medical Association]
日期:2026-01-08
标识
DOI:10.1001/jama.2025.23452
摘要
This interim analysis of an ongoing retrospective cohort study uses data from 5 US health plans to assess safety of a bivalent prefusion F subunit–based respiratory syncytial virus (RSV) vaccine administered during pregnancy during the first full RSV season after US Food and Drug Administration approval (from September 22, 2023, through June 14, 2024).
科研通智能强力驱动
Strongly Powered by AbleSci AI